C. Lemon

The potential advantages of (18)FDG PET/CT-based target volume delineation in radiotherapy planning of head and neck cancer.

I. Kayani, S. Moinuddin, M. Saunders, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The use of DNA double-strand break quantification in radiotherapy.

T. McMillan, S. Mateos, C. Lemon, 2001, International journal of radiation oncology, biology, physics.

18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of occult primary head and neck cancers--an audit and review of published studies.

W. Wong, L. Sonoda, D. Wellsted, 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).

Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer.

J. Franklyn, T. Roques, A. Hackshaw, 2012, The New England journal of medicine.

Thyroid cancer susceptibility polymorphisms: confirmation of loci on chromosomes 9q22 and 14q13, validation of a recessive 8q24 locus and failure to replicate a locus on 5q24

A. Auton, I. Tomlinson, T. Roques, 2012, Journal of Medical Genetics.

Adaptive 18fluoro-2-deoxyglucose positron emission tomography/computed tomography-based target volume delineation in radiotherapy planning of head and neck cancer.

B. Sanghera, I. Kayani, W. Wong, 2011, Clinical oncology (Royal College of Radiologists (Great Britain)).

Results of a multicentre randomised controlled trial of cochlear-sparing intensity-modulated radiotherapy versus conventional radiotherapy in patients with parotid cancer (COSTAR; CRUK/08/004)

S. Bhide, K. Harrington, C. Nutting, 2018, European journal of cancer.

Potential novel application of dual time point SUV measurements as a predictor of survival in head and neck cancer

Martin A Lodge, Bal Sanghera, Wai Lup Wong, 2005, Nuclear medicine communications.